Drug
64Cu-DOTATATE clinical trials
- studies test it
- 4
- open now
- 2
- in phase 3
- 1
- first study started
- 2018
Keep track of what changes. Save the 64Cu-DOTATATE studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2018 (1)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 1
- Phase 3
- 1
- Phase 4
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 3
University of Wisconsin, Madison (1) · Radiomedix, Inc. (1) · Rigshospitalet, Denmark (1) · Vanderbilt-Ingram Cancer Center (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses 64Cu-DOTATATE is read from its arms, and is right about nine times in ten.
Testing it · 4
- Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine TumorsRecruitingPhase 4Vanderbilt-Ingram Cancer CenterNCT06016855Written as Copper Cu 64 Dotatate
- Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine NeoplasmsEnrolling by invitationPhase 2Rigshospitalet, DenmarkNCT05709171Written as 64Cu-Dotatate
- Using Novel Imaging to More Safely Treat Neuroendocrine TumorsCompletedPhase 1University of Wisconsin, MadisonNCT06122610Written as 64Cu-Dotatate
- Imaging of Patients With Known or Suspected Somatostatin Receptor Positive Neuroendocrine Tumors Using Cu64-DOTATATECompletedPhase 3Radiomedix, Inc.NCT03673943Written as 64Cu-DOTATATE
Codes
What other systems call 64Cu-DOTATATE · ClinicalTrials.gg INT006153
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C575629 | 64Cu-DOTATATE | One source ClinicalTrials.gov |
| RxNorm | 2396442 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.